This job posting has expired

Expired on April 1, 2026

Director - Executive Director, Portfolio & Asset Strategy

Full-time237,000 - 286,000 USD/year
OncologyAsset StrategyADCBiopharmaBusiness DevelopmentClinical Development

Job Description

Whitehawk Therapeutics is seeking an accomplished Senior Director - Executive Director of Portfolio & Asset Strategy to lead integrated asset-level strategy across the company’s oncology pipeline. This individual will serve as the strategic quarterback for all three clinical-stage ADC programs, ensuring cohesive and data-driven development strategies from early clinical development through proof-of-concept and beyond.

Responsibilities

  • Lead end-to-end asset strategy for all current and potential future pipeline programs
  • Ensure strategic alignment across assets, balancing scientific opportunity and clinical risk
  • Translate complex scientific data into strategic recommendations for leadership
  • Partner with Clinical Development, Medical Affairs and R&D to shape clinical trial designs
  • Support business development activities and diligence on potential new assets
  • Monitor competitive landscape and emerging clinical data in oncology
  • Engage with key opinion leaders (KOLs) to inform strategy

Qualifications

  • PhD, MD, PharmD, or MS/MBA with strong scientific literacy
  • Prior biopharma strategy consulting experience at established firm
  • 10-15+ years of experience in portfolio / asset strategy or new product planning in the biopharma industry
  • Strong background in oncology
  • Experience in lung cancer or gynecologic cancers highly preferred
  • Demonstrated experience leading asset or portfolio strategy for clinical-stage programs
  • Proven ability to work effectively in small to mid-sized biotech environments

Job Information

Posted

January 31, 2026

Experience Level

lead

Status

Expired